The incidence of oxyphenisatin ingestion in active chronic hepatitis: a prospective controlled study of 29 patients
Cooksley, W.G.; Cowen, A.E.; Powell, L.W.
Australian and New Zealand Journal of Medicine 3(2): 124-128
1973
ISSN/ISBN: 0004-8291 PMID: 4515109 Document Number: 59306
Document emailed within 1 workday
Related Documents
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958Delchier, J.C.; Métreau, J.M.; Lévy, V.G.; Opolon, P.; Dhumeaux, D. 1979: Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France La Nouvelle Presse Medicale 8(37): 2955-2958
Pár, A.; Paál, M.; Kádas, I.; Kerekes, E.; Jávor, T. 1983: Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study) Acta Medica Hungarica 40(1): 17-24
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211
Elefsiniotis, I.S.; Fotos, N.V.; Pantazis, K.D.; Papadeli, D.; Mavrogiannis, C. 2007: Celiac disease in chronic hepatitis C patients under pegylated-interferon plus ribavirin treatment. Preliminary results of a prospective single center study Hepato-Gastroenterology 54(75): 2 PPreceding Table of Contents
Shah, H.A.; Kayani, N.; Sheikh, H.; Jafri, S.W.; Hamid, S.; Khan, A.H. 1995: Comparison of liver histology in chronic active hepatitis C and chronic active hepatitis B Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 14(3): 91-94
Bunchorntavakul, C.; Taweewattanakitbavorn, V.; Atsawarungruangkit, A. 2016: Bone Mineral Density and Renal Function in Chronic Hepatitis B Patients Receiving Nucleotide versus Nucleoside Analogs: a Pilot Prospective Study Journal of the Medical Association of Thailand 99(Suppl 2): S1-S8
Mitchel, L.S.; Jeffers, L.J.; Reddy, K.R.; Cheinquer, H.; Coelho-Little, E.; Moreda, R.; Parker, T.; Silva, M.; Li, X.M.; de Medina, M. 1993: Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III American Journal of Gastroenterology 88(7): 1027-1034
Ludwig, D.; Stange, E.F. 1999: Efficacy of azathioprine in the treatment of chronic active Crohn's disease: prospective one-year follow-up study. German Imurek Study Group Zeitschrift für Gastroenterologie 37(11): 1085-1091
Nielsen, J.O.; Dietrichson, O.; Juhl, E. 1974: Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme Lancet 2(7886): 913-915
Colombo, M.; Vernace, S.J.; Paronetto, F. 1977: T and B lymphocytes in patients with chronic active hepatitis (CAH) Clinical and Experimental Immunology 30(1): 4-9
Pirotte, J.; Rauber, G.; Ruyters, L. 1972: Chronic persistent hepatitis and chronic active hepatitis. Correlations between the histological aspects, clinical picture, biological and immunological data Archives Francaises des Maladies de l'Appareil Digestif 61(1): 7-18
Langer, H.E.; Birth, U. 1988: Patient education in chronic polyarthritis. 3. Intermediate results of a prospective, controlled study of the effectiveness and side effects of patient seminars for polyarthritis patients Zeitschrift für Rheumatologie 47(1): 43-51
Rea, F.; Stoppoloni, G.; Stefani, M. 1973: Immunoglobulins in active chronic hepatitis in childhood: study of 3 cases La Pediatria 81(3): 388-406
Patorska-Mach, E.; Pieciński, Z.; Siuciak, J. 1972: Incidence of Australia antigen in patients with acute virus hepatitis and chronic hepatic disorders following virus hepatitis in our records Polski Tygodnik Lekarski 27(50): 1975-1977
László, B.; Kendrey, G. 1979: Chronic active hepatitis in patients taking phenlaxin-containing lexatives Orvosi Hetilap 120(19): 1133-1136
Tandy, B.; Mark, H.I. 1982: Treatment of the chronic active hepatitis B patient in dental practice: a case study General Dentistry 30(2): 124-127
Anzueto, A.; Jubran, A.; Ohar, J.A.; Piquette, C.A.; Rennard, S.I.; Colice, G.; Pattishall, E.N.; Barrett, J.; Engle, M.; Perret, K.A.; Rubin, B.K. 1997: Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial JAMA 278(17): 1426-1431
Xiao, G.-M.; He, K.-Y.; Jia, W.-D.; Lei, C.-L.; Yang, Z. 2009: Case-controlled study of entecavir treatment for chronic severe hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(1): 56-58
Hou, S.R.; Huang, Y.C.; Ling, S.S. 1988: Effect of ribonucleic acid on serum protein in patients with chronic active hepatitis Zhonghua Nei Ke Za Zhi 27(5): 272-274; 325